PMID- 33947339 OWN - NLM STAT- MEDLINE DCOM- 20210601 LR - 20220422 IS - 1471-2334 (Electronic) IS - 1471-2334 (Linking) VI - 21 IP - 1 DP - 2021 May 4 TI - HLA-G polymorphism impacts the outcome of oral HPV infections in women. PG - 419 LID - 10.1186/s12879-021-06079-7 [doi] LID - 419 AB - BACKROUND: Human leukocyte antigen (HLA)-G may have an important role in the natural history of human papillomavirus (HPV) infection. Our aim was to evaluate the role of HLA-G in the outcome of genital and oral HPV infections in women. METHODS: Analyses included 306 women from the Finnish Family HPV-study and were followed-up for six years. Genital and oral samples were tested for 24 different HPV types with multiplex HPV genotyping. HLA-G alleles were determined through direct DNA-sequencing. Unconditional logistic regression was used to determine the associations between HLA-G genotypes and HPV infection outcomes. RESULTS: Ten HLA-G alleles were identified. Most common HLA-G genotypes were the wild type G*01:01:01/01:01:01 (31.3%) followed by G*01:01:01/01:01:02 (26.8%). G*01:01:01/01:01:01 genotype was associated with increased risk of oral HPV infections by any HPV type or single-type with OR = 1.86 (95% CI 1.14-3.04, P = 0.01) and 2.22 (95% CI 1.14-3.71, P = 0.02), respectively. G*04:01+ allele and the G*01:01:01/01:04:01 genotype both protected from any and single oral HPV infections; OR = 0.46 (95% CI 0.23-0.89, P = 0.02) and 0.53 (95% CI 0.23-0.97, P = 0.03), respectively. G*01:01:02/01:04:01 genotype increased significantly the risk of infertility and its treatments, with respective OR = 5.06 (95% CI 1.22-21.02, P = 0.03) and OR = 9.07 (95% CI 1.22-39.50, P = 0.03). Both HLA-G alleles and genotypes showed several significant associations with the outcomes of oral HPV infections, but none of them had any impact on the outcomes of genital HPV infections in these women. CONCLUSIONS: The host HLA-G genotypes appear to impact the outcomes of oral HPV infections in women but have little if any effect on genital HPV status or infection outcomes. FAU - Jaakola, Anna AU - Jaakola A AUID- ORCID: 0000-0001-5549-5280 AD - Turku University Hospital, University of Turku, Turku, Finland. ajjaak@utu.fi. AD - Department of Obstetrics and Gynecology, Kymenlaakso Central Hospital, Kotkantie 41, 48210, Kotka, Finland. ajjaak@utu.fi. FAU - Roger, Michel AU - Roger M AD - Centre de Recherche du CHUM, Montreal, Canada. AD - Departement de Microbiologie, Infectiologie et Immunologie,de l'Universite de Montreal, Montreal, Canada. FAU - Faucher, Marie-Claude AU - Faucher MC AD - Centre de Recherche du CHUM, Montreal, Canada. FAU - Syrjanen, Kari AU - Syrjanen K AD - Department of Clinical Research, Biohit Oyj, Helsinki, Finland. FAU - Grenman, Seija AU - Grenman S AD - Turku University Hospital, University of Turku, Turku, Finland. FAU - Syrjanen, Stina AU - Syrjanen S AD - Department of Oral Pathology and Radiology, University of Turku, Turku, Finland. AD - Department of Pathology, Turku University Hospital, University of Turku, Turku, Finland. FAU - Louvanto, Karolina AU - Louvanto K AD - Department of Oral Pathology and Radiology, University of Turku, Turku, Finland. AD - Department of Obstetrics and Gynecology, Tampere University and Tampere University Hospital, Tampere, Finland. LA - eng PT - Journal Article DEP - 20210504 PL - England TA - BMC Infect Dis JT - BMC infectious diseases JID - 100968551 RN - 0 (HLA-G Antigens) SB - IM MH - Adolescent MH - Adult MH - Alleles MH - Female MH - Finland MH - Genotype MH - HLA-G Antigens/*genetics MH - Humans MH - Infertility, Female/genetics/virology MH - Male MH - Middle Aged MH - Mouth Diseases/*virology MH - Mouth Mucosa/virology MH - Papillomaviridae/genetics MH - Papillomavirus Infections/*genetics/virology MH - *Polymorphism, Genetic MH - Pregnancy MH - Sequence Analysis, DNA MH - Young Adult PMC - PMC8097798 OTO - NOTNLM OT - Genotype OT - HLA-G OT - HPV OT - Human papilloma virus OT - Infection OT - Oral COIS- Nothing to declare. EDAT- 2021/05/06 06:00 MHDA- 2021/06/02 06:00 PMCR- 2021/05/04 CRDT- 2021/05/05 05:36 PHST- 2021/02/08 00:00 [received] PHST- 2021/04/15 00:00 [accepted] PHST- 2021/05/05 05:36 [entrez] PHST- 2021/05/06 06:00 [pubmed] PHST- 2021/06/02 06:00 [medline] PHST- 2021/05/04 00:00 [pmc-release] AID - 10.1186/s12879-021-06079-7 [pii] AID - 6079 [pii] AID - 10.1186/s12879-021-06079-7 [doi] PST - epublish SO - BMC Infect Dis. 2021 May 4;21(1):419. doi: 10.1186/s12879-021-06079-7.